Cite
Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery: Rationale and design of the multicenter, randomized PROCTOR trial.
MLA
de Winter, Ruben W., et al. “Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery: Rationale and Design of the Multicenter, Randomized PROCTOR Trial.” American Heart Journal, vol. 257, Mar. 2023, pp. 20–29. EBSCOhost, https://doi.org/10.1016/j.ahj.2022.11.014.
APA
de Winter, R. W., Walsh, S. J., Hanratty, C. G., Spratt, J. C., Sprengers, R. W., Twisk, J. W. R., Vegting, I., Schumacher, S. P., Bom, M. J., Hoek, R., Verouden, N. J., Delewi, R., Nap, A., & Knaapen, P. (2023). Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery: Rationale and design of the multicenter, randomized PROCTOR trial. American Heart Journal, 257, 20–29. https://doi.org/10.1016/j.ahj.2022.11.014
Chicago
de Winter, Ruben W, Simon J Walsh, Colm G Hanratty, James C Spratt, Ralf W Sprengers, Jos W R Twisk, Iris Vegting, et al. 2023. “Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery: Rationale and Design of the Multicenter, Randomized PROCTOR Trial.” American Heart Journal 257 (March): 20–29. doi:10.1016/j.ahj.2022.11.014.